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Enzootic bovine leucosis is an infectious disease of cattle 
induced by bovine leukemia virus (BLV). This retrovirus is 
worldwide distributed, and all cattle breeds are susceptible, 
although the incidence is higher in dairy cows and in animals 
over 2 years of age and increases with age [1]. Approximately 
sixty percent of infected animals do not display clinical signs of 
disease, and these animals are referred to as asymptomatic or 
aleukemic. Approximately 30–40% of BLV carriers will develop a 
persistent lymphocytosis, while fewer than 5% develop malignant 
lymphosarcoma [2]. The disease is difficult to control, and only a 
few countries have been able to eradicate the disease.
BLV infection impedes the normal function of the immune 
system, affecting cells of the innate and adaptive immunity [3]. 
A study performed in 1989 reported a possible impairment of 
the immune response against rotavirus in BLV-infected animals 
[4]. Considering that BLV is endemic in many countries and 
approximately 60% of the animals are asymptomatic, it is important 
to know how BLV infection impacts the immunogenicity of 
vaccines compulsory applied to cattle populations. Despite strong 
evidence of abnormal immune signalling and functioning, little 
research has investigated the large-scale effects of BLV infection 
on host immunity and resistance to other infectious diseases. 
Work performed along the last 10 years have shown that that BLV 
positive (by serology) dairy cows exhibit a decreased or modified 
immune response against primo-vaccination to a bacteria or 
inactivated virus-vaccine as compared to non-infected cows [5-8]. 
A compromised immune response to vaccination will be 
particularly detrimental for foot and mouth disease (FMD) control. 
FMD is endemic in many parts of Asia, Africa, and South America, 
where vaccination of susceptible populations is compulsory used 
as the major tool to prevent outbreaks of this extremely contagious 
virus. FMD has global consequences, costing an estimated USD $6–
$21 billion each year in prevention expenditures and agricultural 
damage. A significant portion of this cost is undertaken by low- 
and middle-income countries that suffer huge economic losses 
from trade restrictions, both of animals and derived products 
[9,10]. 
Commercial vaccine formulations used in FMD vaccination 
campaigns are based on BEI-inactivated viral particles, and usually 
contain more than one virus strain, as immune responses induced 
by vaccination are not cross-protective between strains [11]. Pro-
tection against FMDV has been related to antibody levels induced 
by vaccination [12]. High levels of serum neutralizing antibodies 
and particularly, IgG1 levels are related to protection in vaccinated 
cattle [13,14]. Maintaining high levels of total antibodies against 
FMDV is paramount to prevent outbreaks. The well-characterized 
immune response elicited against FMDV using the current com-
mercial vaccines allowed the analysis of the effect of BLV on the 
immune response elicited by FMD vaccine. 
FMD vaccination represents then an excellent model to study 
the effect of BLV in the development of  immunity. FMD vaccines are 
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well-controlled in many South-American countries. In Argentina, 
vaccination campaigns are applied under the supervision of the 
national authorities, certifying cold chain and correct application. 
Another advantage is the availability of ELISAs that allow a precise 
correlation with that can be used to study FMD-vaccine efficacy 
in the field [15,16]. Apart from assays measuring total antibodies, 
like liquid phase blocking ELISA used since the late eighties 
[17], there are also simple high-throughput serological tools to 
characterize the quality of the antibody response [14]. 
The quality of vaccine-induced antibodies, defined by isotype 
profile and avidity, has been identified as a defining factor in 
efficacy. FMDV isotype ELISAs for cattle sera were developed in 
the nineties [13]. They are indirect tests used to titrate anti FMDV 
IgG1 and IgG2 in sera. The rate between IgG1 and IgG2 titers has 
been related to protection against FMDV specially when studying 
cross- protection [14,18]. Isotypes bring information of the type 
of immune response, if it is related to antibody-mediated cellular 
responses or if they are mainly neutralizing responses. Avidity is 
another parameter of the “functional affinity” of specific antibodies. 
It is related to the interaction between polyclonal antibodies 
in a sample and the bound antigen. Avidity is influenced by the 
antibody serotype, their epitope-paratope affinity, the number 
of antibodies and their aminoacidic sequence. When vaccines 
stimulate the acquired immunity, antigen-specific B cells undergo 
somatic hypermutation and affinity-based selection, resulting in B 
cells that produce antibodies with increased avidity over germline 
antibodies. Avidity can be considered a landmark of efficient 
vaccination [19] and has been related to protection for many 
vaccines and diseases [20], used to discriminate between chronic 
and acute infections [21] and correlated to capacity of antibodies 
to neutralize viral infection in cultured cells [20,22].
Analysis of the isotypes of the antibodies induced against a vi-
rus strain in primo-vaccinated cattle revealed that IgM, IgG1 and 
IgG2 titres increased in both positive (BLV+) and negative (BLV-) 
heifers following FMD immunization, although IgM and IgG1 tit-
ters were higher in non-infected animals [5]. Levels of IgG2 can 
explain why the difference in antibody titters was only marginal-
ly significant when total antibodies were measured. The avidity 
index was lower in seropositive animals than that seronegative, 
meaning a reduced capacity of developing a protective immune 
response. These results demonstrated that BLV infection in dairy 
cattle modified the profile of antibody response to FMD pri-
mo-vaccination, biasing the isotype switch towards IgG2 though 
total antibody levels were marginally affected. These differences 
may be caused by the cytokine modulation exerted by BLV.
In a larger study [23] we measured anti FMDV antibodies 
from two-hundred milking cows (>2 years old) selected based on 
their BLV-serologic status (100 BLV+ and 100 BLV-). The animals 
were in two large farms in Argentina (500 animals each), one 
with low and another with high BLV prevalence. The aim of this 
study was to investigate if BLV-status could interfere with the 
efficacy of the FMDV-vaccination campaign. This is of interest 
in FMDV-endemic regions since the total FMDV-antibody titers 
induced through vaccination are necessary to prevent disease 
outbreaks. Here we showed that after repeated vaccination, levels 
and avidity of anti-FMDV antibodies were similar between BLV + 
and BLV- animals. Although primo-vaccination may be affected 
[5], repeated vaccination probably weakens this effect at a herd 
level, as animals may get infected with BLV at different times 
before or after their primo-vaccination. The use of avidity in this 
study allowed detecting individual vaccine failures that cannot 
be accounted by just measuring total antibodies. Our results 
suggested that BLV-status did not compromise the efficacy of 
routine FMDV-vaccination in cattle. 
The use of serological high-throughput assays allowed to study 
if FMD vaccination was affected by the animal´s BLV serological 
status. These simple tools were useful to characterize the immune 
response at individual level and get a closer insight on the effects 
of this important viral disease of dairy cattle, revealing individual 
vaccine failures and helping to better characterizing the effect of 
BLV infection on the immune response induced by vaccination, at 
a herd level. These serological assays constitute important tools to 
assess vaccine performance in the field.
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